These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 22648705

  • 1. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
    Bernthal NM, Federman N, Eilber FR, Nelson SD, Eckardt JJ, Eilber FC, Tap WD.
    Cancer; 2012 Dec 01; 118(23):5888-93. PubMed ID: 22648705
    [Abstract] [Full Text] [Related]

  • 2. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
    Lewis VO, Raymond K, Mirza AN, Lin P, Yasko AW.
    Clin Orthop Relat Res; 2006 Sep 01; 450():60-6. PubMed ID: 16906104
    [Abstract] [Full Text] [Related]

  • 3. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
    Harting MT, Blakely ML, Jaffe N, Cox CS, Hayes-Jordan A, Benjamin RS, Raymond AK, Andrassy RJ, Lally KP.
    J Pediatr Surg; 2006 Jan 15; 41(1):194-9. PubMed ID: 16410132
    [Abstract] [Full Text] [Related]

  • 5. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S, Shin SJ, Jung M, Jeong J, Lee YJ, Shin KH, Roh JK, Rha SY.
    Oncology; 2011 Jan 15; 80(1-2):107-17. PubMed ID: 21677455
    [Abstract] [Full Text] [Related]

  • 6. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A.
    Ann Surg Oncol; 2007 Oct 15; 14(10):2887-95. PubMed ID: 17653803
    [Abstract] [Full Text] [Related]

  • 7. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G, Longhi A, Cesari M, Versari M, Bertoni F.
    Cancer; 2006 Jun 15; 106(12):2701-6. PubMed ID: 16691623
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G, Longhi A, Forni C, Fabbri N, Briccoli A, Barbieri E, Mercuri M, Balladelli A, Ferrari S, Picci P.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):505-11. PubMed ID: 17118571
    [Abstract] [Full Text] [Related]

  • 9. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
    Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA.
    N Engl J Med; 1986 Jun 19; 314(25):1600-6. PubMed ID: 3520317
    [Abstract] [Full Text] [Related]

  • 10. Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series.
    Müller CR, Smeland S, Bauer HC, Saeter G, Strander H.
    Acta Oncol; 2005 Jun 19; 44(5):475-80. PubMed ID: 16118081
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P.
    Eur J Cancer; 2005 Dec 19; 41(18):2836-45. PubMed ID: 16298125
    [Abstract] [Full Text] [Related]

  • 12. Tissue necrosis after chemotherapy in osteosarcoma as the important prognostic factor.
    Sami SH, Rafati AH, Hodjat P.
    Saudi Med J; 2008 Aug 19; 29(8):1124-9. PubMed ID: 18690304
    [Abstract] [Full Text] [Related]

  • 13. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F.
    Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K.
    Cancer; 2004 Feb 15; 100(4):818-25. PubMed ID: 14770440
    [Abstract] [Full Text] [Related]

  • 15. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
    Bacci G, Ferrari S, Ruggieri P, Biagini R, Fabbri N, Campanacci L, Bacchini P, Longhi A, Forni C, Bertoni F.
    Acta Orthop Scand; 2001 Apr 15; 72(2):167-72. PubMed ID: 11372948
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P.
    Cancer; 2006 Mar 01; 106(5):1154-61. PubMed ID: 16421923
    [Abstract] [Full Text] [Related]

  • 17. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
    Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S, Yamamoto N.
    Anticancer Res; 1998 Mar 01; 18(1B):657-66. PubMed ID: 9584049
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
    Adamkova Krakorova D, Vesely K, Zambo I, Tucek S, Tomasek J, Jureckova A, Janicek P, Cerny J, Pazourek L, Ondrusek S, Selingerova I.
    Klin Onkol; 2012 Mar 01; 25(5):346-58. PubMed ID: 23102196
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jeon DG.
    Ann Surg Oncol; 2008 Mar 01; 15(3):906-14. PubMed ID: 18163171
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P, Albrecht M, Rühl U, Fengler R, Kulozik AE, Henze G.
    Eur J Cancer; 2009 Sep 01; 45(14):2447-51. PubMed ID: 19596190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.